Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Japan. The trial aims for comparison of the effect on glycaemic
control of liraglutide, compared to sulfonylurea (SU treatment), as assessed by HbA1c after
24 and 52 weeks in subjects with type 2 diabetes. Trial has a randomisation period of 24
weeks followed by a 28 week extension period, in total 52 weeks.